Sarkander Jana, Hojyo Shintaro, Tokoyoda Koji
Osteoimmunology, Deutsches Rheuma-Forschungszentrum (DRFZ) , Berlin, Germany.
Clin Transl Immunology. 2016 Dec 23;5(12):e120. doi: 10.1038/cti.2016.81. eCollection 2016 Dec.
The concept of immune memory forms the biological basis for vaccination programs. Despite advancements in the field of immune memory and vaccination, most current vaccines are evaluated by magnitude of antigen-specific antibody titers in serum or mucosa after vaccination. It has been shown, however, that antibody-mediated humoral immune memory is established regardless of the magnitude and duration of immune reactions, suggesting that assessment of vaccine efficacy should be performed for several years after vaccination. This long-term investigation is disadvantageous for prevalent and pandemic infections. Long-lived memory plasma cells and memory helper T cells which contribute to humoral immune memory are generated in the bone marrow after migration of memory cell precursors through bloodstream. Thus, it may be a novel evaluation strategy to assess the precursors of memory cells in the blood in the early phase of the immune reaction(s). We here review recent advances on the generation and maintenance of immune memory cells involved in humoral immunity and introduce a current concept of direct and short-term assessment of humoral immune memory formation upon vaccination as a correlate of protection.
免疫记忆的概念构成了疫苗接种计划的生物学基础。尽管免疫记忆和疫苗接种领域取得了进展,但目前大多数疫苗是通过接种后血清或黏膜中抗原特异性抗体滴度的大小来评估的。然而,已经表明,抗体介导的体液免疫记忆的建立与免疫反应的大小和持续时间无关,这表明疫苗效力的评估应在接种后数年进行。这种长期研究对于流行和大流行感染来说是不利的。在记忆细胞前体通过血流迁移后,骨髓中会产生有助于体液免疫记忆的长寿记忆浆细胞和记忆辅助性T细胞。因此,在免疫反应早期评估血液中记忆细胞的前体可能是一种新的评估策略。我们在此综述了参与体液免疫的免疫记忆细胞产生和维持的最新进展,并介绍了一种当前的概念,即接种疫苗后直接和短期评估体液免疫记忆形成作为保护的相关指标。